Brown-Forman Reports Q3 Sales Decline, Lower EPS Amid Challenging Environment; Completes $400M Share Repurchase
Summary
Brown-Forman reported a 2% decline in net sales and an 8% drop in diluted EPS for the nine months ended January 31, 2026, but completed a significant $400 million share repurchase program and reiterated its fiscal 2026 guidance for low-single digit organic declines.
Key Events
-
Financial Performance Declines
For the nine months ended January 31, 2026, net sales decreased 2% to $3.016 billion, and diluted earnings per share (EPS) decreased 8% to $1.41, primarily due to the absence of a prior-year gain on the sale of an equity method investment.
-
Significant Share Repurchase Completed
The company completed a $400 million share repurchase program in December 2025, authorized by the Board of Directors on October 1, 2025.
-
Guidance Reaffirmed
Management reiterated its fiscal 2026 outlook, anticipating low-single digit declines in both organic net sales and organic operating income, reflecting a challenging operating environment.
-
Improved Operating Cash Flow
Cash provided by operating activities significantly increased to $709 million for the nine months ended January 31, 2026, up from $446 million in the prior year.
Analysis
Brown-Forman's latest 10-Q reveals a mixed financial picture for the nine months ended January 31, 2026. While reported net sales decreased by 2% and diluted EPS fell by 8%, the latter was significantly impacted by the absence of a large one-time gain from a prior-year divestiture. The company demonstrated strong operational cash flow and completed a substantial $400 million share repurchase program, which is a notable return of capital to shareholders, especially with the stock trading near 52-week lows. However, the reiterated guidance for low-single digit organic declines in both net sales and operating income indicates that management anticipates continued macroeconomic and geopolitical headwinds. Investors should monitor the effectiveness of ongoing restructuring and distributor transitions in driving future growth and margin improvement.
At the time of this filing, BFB was trading at $26.37 on NYSE in the Manufacturing sector, with a market capitalization of approximately $12.2B. The 52-week trading range was $25.16 to $38.85. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.